-
1
-
-
73449101512
-
Lessons from 60 years of pharmaceutical innovation
-
Munos B. (2009) Lessons from 60 years of pharmaceutical innovation. Nat. Rev. Drug Discov. 12:959-968.
-
(2009)
Nat. Rev. Drug Discov
, vol.12
, pp. 959-968
-
-
Munos, B.1
-
2
-
-
84055214441
-
-
Economist Intelligence Unit (2011) The future of healthcare in Europe. http://www.janssen-emea.com/sites/default/files/The-Future-Of-Healthcare-In- Europe.pdf
-
(2011)
The Future of Healthcare in Europe
-
-
-
3
-
-
84865677102
-
From sick care to health care-reengineering prevention into the U. S. System
-
Marvasti F, Stafford RS. (2012) From sick care to health care-reengineering prevention into the U. S. system. N Engl J Med. 367(10):889-891
-
(2012)
N Engl J Med
, vol.367
, Issue.10
, pp. 889-891
-
-
Marvasti, F.1
Stafford, R.S.2
-
4
-
-
4344645978
-
Can the pharmaceutical industry reduce attrition rates?
-
Kola I, Landis J. (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3(8):711-715. (Pubitemid 39173511)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.8
, pp. 711-715
-
-
Kola, I.1
Landis, J.2
-
5
-
-
77649234756
-
How to improve R&D productivity: The pharmaceutical industry's grand challenge
-
Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH et al (2010) How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov. 9(3):203-214.
-
(2010)
Nat Rev Drug Discov
, vol.9
, Issue.3
, pp. 203-214
-
-
Paul, S.M.1
Mytelka, D.S.2
Dunwiddie, C.T.3
Persinger, C.C.4
Munos, B.H.5
-
6
-
-
57649119801
-
Requirements for a lead compound to become a clinical candidate
-
Hefti FF (2008) Requirements for a lead compound to become a clinical candidate. BMC Neurosci. 9 Suppl 3:S7.
-
(2008)
BMC Neurosci
, vol.9
, Issue.SUPPL. 3
-
-
Hefti, F.F.1
-
7
-
-
79955766246
-
Towards new business models for R&D for novel antibiotics
-
So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, et al (2011) Towards new business models for R&D for novel antibiotics. Drug Resist Updat. 14(2):88-94.
-
(2011)
Drug Resist Updat
, vol.14
, Issue.2
, pp. 88-94
-
-
So, A.D.1
Gupta, N.2
Brahmachari, S.K.3
Chopra, I.4
Munos, B.5
-
9
-
-
77955652343
-
Reaping the benefits of biomedical research: Partnerships required
-
Portilla LM, Alving B (2010) Reaping the benefits of biomedical research: partnerships required. Sci Transl Med. 2(35):35cml7
-
(2010)
Sci Transl Med
, vol.2
, Issue.35
-
-
Portilla, L.M.1
Alving, B.2
-
10
-
-
84877120013
-
Improving R&D productivity of pharmaceutical companies through public-private partnership: Experiences from the Innovative Medicines Initiative
-
Laverty H, Gunn M, Goldman M. (2012) Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative. Expert Rev. Pharmacoecon & Outcomes Res 12(5):545-548
-
(2012)
Expert Rev. Pharmacoecon & Outcomes Res
, vol.12
, Issue.5
, pp. 545-548
-
-
Laverty, H.1
Gunn, M.2
Goldman, M.3
-
11
-
-
67349124872
-
The global portfolio of new antimalarial medicines under development
-
Olliaro P, Wells T N C (2009) The Global Portfolio of New Antimalarial Medicines Under Development. Clin. Pharmacol. Ther 85(6):584-595
-
(2009)
Clin. Pharmacol. Ther
, vol.85
, Issue.6
, pp. 584-595
-
-
Olliaro, P.1
Wells, T.N.C.2
-
12
-
-
84866739808
-
Drug discovery in pharmaceutical industry: Productivity challenges and trends
-
Khanna I (2012) Drug discovery in pharmaceutical industry: productivity challenges and trends, Drug Discov. Today 17(19-20):1088-102
-
(2012)
Drug Discov. Today
, vol.17
, Issue.19-20
, pp. 1088-1102
-
-
Khanna, I.1
-
13
-
-
84878488692
-
Public-private partnerships as driving forces in the quest for innovative medicines
-
Goldman M, Compton C, Mittleman BB (2013) Public-private partnerships as driving forces in the quest for innovative medicines. Clin Transl Med. 2(1):2.
-
(2013)
Clin Transl Med
, vol.2
, Issue.1
, pp. 2
-
-
Goldman, M.1
Compton, C.2
Mittleman, B.B.3
-
14
-
-
39649084919
-
The FDA critical path initiative and its influence on new drug development
-
DOI 10.1146/annurev.med.59.090506.155819
-
Woodcock J, Woosley R (2008) The FDA critical path initiative and its influence on new drug development. Annu Rev Med 59:1-12. (Pubitemid 351287920)
-
(2008)
Annual Review of Medicine
, vol.59
, pp. 1-12
-
-
Woodcock, J.1
Woosley, R.2
-
15
-
-
57649120069
-
NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders
-
Brady LS, Winsky L, Goodman W, Oliveri ME, Stover E (2009) NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders. Neuropsychopharmacol. 34(1):229-43.
-
(2009)
Neuropsychopharmacol
, vol.34
, Issue.1
, pp. 229-243
-
-
Brady, L.S.1
Winsky, L.2
Goodman, W.3
Oliveri, M.E.4
Stover, E.5
-
16
-
-
84857237851
-
The innovative medicines initiative: A European response to the innovation challenge
-
Goldman M (2012) The innovative medicines initiative: a European response to the innovation challenge. Clin Pharmacol Ther. 91(3):4l8-25.
-
(2012)
Clin Pharmacol Ther
, vol.91
, Issue.3
-
-
Goldman, M.1
-
17
-
-
77951494873
-
Targeted cancer therapies in the twenty-first century: Lessons from imatinib
-
Stegmeier F, Warmuth M, Sellers WR, Dorsch M. (2010) Targeted cancer therapies in the twenty-first century: lessons from imatinib. Clin Pharmacol Ther. 87(5):543-52.
-
(2010)
Clin Pharmacol Ther
, vol.87
, Issue.5
, pp. 543-552
-
-
Stegmeier, F.1
Warmuth, M.2
Sellers, W.R.3
Dorsch, M.4
-
18
-
-
84875448716
-
Phenotypic vs. Target-based drug discovery for first-in-class medicines
-
Swinney DC. (2013) Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther 93(4):299-301.
-
(2013)
Clin Pharmacol Ther
, vol.93
, Issue.4
, pp. 299-301
-
-
Swinney, D.C.1
-
19
-
-
84875471298
-
Systems-based discovery advances drug development
-
Waldman SA, Terzic A (2013) Systems-based discovery advances drug development. Clin Pharmacol Ther 93(4):285-7.
-
(2013)
Clin Pharmacol Ther
, vol.93
, Issue.4
, pp. 285-287
-
-
Waldman, S.A.1
Terzic, A.2
-
20
-
-
84871277043
-
Solving the lost in translation problem: Improving the effectiveness of translational research
-
Ergorul C, Levin LA (2013) Solving the lost in translation problem: improving the effectiveness of translational research. Curr Opin Pharmacol 13(1):108-14.
-
(2013)
Curr Opin Pharmacol
, vol.13
, Issue.1
, pp. 108-114
-
-
Ergorul, C.1
Levin, L.A.2
-
21
-
-
77950679333
-
Can animal models of disease reliably inform human studies?
-
van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S et al (2010) Can animal models of disease reliably inform human studies? PLoS Med. 7(3):e1000245
-
(2010)
PLoS Med
, vol.7
, Issue.3
-
-
Van Der Worp, H.B.1
Howells, D.W.2
Sena, E.S.3
Porritt, M.J.4
Rewell, S.5
-
22
-
-
80055088241
-
Believe it or not: How much can we rely on published data on potential drug targets?
-
Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 10(9):712
-
(2011)
Nat Rev Drug Discov
, vol.10
, Issue.9
, pp. 712
-
-
Prinz, F.1
Schlange, T.2
Asadullah, K.3
-
23
-
-
84859169880
-
Drug development: Raise standards for preclinical cancer research
-
Begley CG, Ellis LM (2012) Drug development: Raise standards for preclinical cancer research. Nature 483(7391):531-3.
-
(2012)
Nature
, vol.483
, Issue.7391
, pp. 531-533
-
-
Begley, C.G.1
Ellis, L.M.2
-
24
-
-
84933675226
-
Deep impact: Unintended consequences of journal rank
-
Brembs B, Button K, Munafo M (2013) Deep impact: unintended consequences of journal rank. Front Hum Neurosci. 7:291
-
(2013)
Front Hum Neurosci
, vol.7
, pp. 291
-
-
Brembs, B.1
Button, K.2
Munafo, M.3
-
25
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
DOI 10.1038/414782a
-
Zimmet P, Alberti K G MM, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 404:782-787 (Pubitemid 34000780)
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.M.M.2
Shaw, J.3
-
27
-
-
84864378869
-
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy
-
Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C et al (2012) Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy. Diabetes 61(8):2187-2194
-
(2012)
Diabetes
, vol.61
, Issue.8
, pp. 2187-2194
-
-
Williams, W.W.1
Salem, R.M.2
McKnight, A.J.3
Sandholm, N.4
Forsblom, C.5
-
28
-
-
84866889255
-
New susceptibility loci associated with kidney disease in type 1 diabetes
-
Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C et al (2012) New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet. 8(9):el002921
-
(2012)
PLoS Genet
, vol.8
, Issue.9
-
-
Sandholm, N.1
Salem, R.M.2
McKnight, A.J.3
Brennan, E.P.4
Forsblom, C.5
-
29
-
-
42349112088
-
Genome-wide association studies for complex traits: Consensus, uncertainty and challenges
-
DOI 10.1038/nrg2344, PII NRG2344
-
McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9(5):356-69. (Pubitemid 351556063)
-
(2008)
Nature Reviews Genetics
, vol.9
, Issue.5
, pp. 356-369
-
-
McCarthy, M.I.1
Abecasis, G.R.2
Cardon, L.R.3
Goldstein, D.B.4
Little, J.5
Ioannidis, J.P.A.6
Hirschhorn, J.N.7
-
30
-
-
84867854875
-
Bag of Naive Bayes: Biomarker selection and classification from genome-wide SNP data
-
Sambo F, Trifoglio E, Di Camillo B, Toffolo GM, Cobelli C (2012) Bag of Naive Bayes: biomarker selection and classification from genome-wide SNP data. BMC Bioinformatics 13 Suppl 14:S2.
-
(2012)
BMC Bioinformatics
, vol.13
, Issue.SUPPL. 14
-
-
Sambo, F.1
Trifoglio, E.2
Di Camillo, B.3
Toffolo, G.M.4
Cobelli, C.5
-
31
-
-
79959682988
-
Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein BlOO-only mice
-
Heinonen SE, Merentie M, Hedman M, Makinen PI, Loponen E, et al (2011) Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein BlOO-only mice. Cardiovasc Diabetol 10:59.
-
(2011)
Cardiovasc Diabetol
, vol.10
, pp. 59
-
-
Heinonen, S.E.1
Merentie, M.2
Hedman, M.3
Makinen, P.I.4
Loponen, E.5
-
32
-
-
33645231857
-
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
-
Breivik H, Collett B, Ventafridda V, Cohen R, et Al (2006) Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment, Eur. J. Pain 10(4):287
-
(2006)
Eur. J. Pain
, vol.10
, Issue.4
, pp. 287
-
-
Breivik, H.1
Collett, B.2
Ventafridda, V.3
Cohen, R.4
-
33
-
-
40849119571
-
Predictive validity of animal pain models? A comparison of the pharmacokineticpharmacodynamic relationship for pain drugs in rats and humans
-
Whiteside GT, Adedoyin A, Leventhal L (2008) Predictive validity of animal pain models? A comparison of the pharmacokineticpharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacol 54(5):767-75.
-
(2008)
Neuropharmacol
, vol.54
, Issue.5
, pp. 767-775
-
-
Whiteside, G.T.1
Adedoyin, A.2
Leventhal, L.3
-
34
-
-
84875412180
-
The pattern and time course of somatosensory changes in the human UVB sunburn model reveal the presence of peripheral and central sensitization
-
Gustorff B, Sychab T, Lieba-Samala D, Rolkec R, Treede RD, et al (2013) The pattern and time course of somatosensory changes in the human UVB sunburn model reveal the presence of peripheral and central sensitization Pain 154(4):586-597
-
(2013)
Pain
, vol.154
, Issue.4
, pp. 586-597
-
-
Gustorff, B.1
Sychab, T.2
Lieba-Samala, D.3
Rolkec, R.4
Treede, R.D.5
-
36
-
-
79960082885
-
CXCL5 mediates UVB irradiation-induced
-
Dawes JM, Calvo M, Perkins JR, Paterson KJ, Kiesewetter H, et al (2011) CXCL5 Mediates UVB Irradiation-Induced Pain Sci Transl Med 3(90):90ra60
-
(2011)
Pain Sci Transl Med
, vol.3
, Issue.90
-
-
Dawes, J.M.1
Calvo, M.2
Perkins, J.R.3
Paterson, K.J.4
Kiesewetter, H.5
-
37
-
-
84871392797
-
Systems biology approaches to finding novel pain mediators
-
Antunes-Martins A, Perkins JR, Lees J, Hildebrandt T, Orengo C, et al (2013) Systems biology approaches to finding novel pain mediators, WIREs Syst Biol Med 5(1):11-35
-
(2013)
WIREs Syst Biol Med
, vol.5
, Issue.1
, pp. 11-35
-
-
Antunes-Martins, A.1
Perkins, J.R.2
Lees, J.3
Hildebrandt, T.4
Orengo, C.5
-
38
-
-
65449119595
-
Economic cost of autism in the UK
-
Knapp M, Romeo R, Beecham J (2009) Economic cost of autism in the UK. Autism 13(3):317-336.
-
(2009)
Autism
, vol.13
, Issue.3
, pp. 317-336
-
-
Knapp, M.1
Romeo, R.2
Beecham, J.3
-
39
-
-
84902202442
-
-
http://www.sagecrossingfoundation.org/pdfs/Economic-Impact-of-Adut- Autism-2014-2028.pdf
-
-
-
-
40
-
-
84884211527
-
Translational approaches to the biology of Autism: False dawn or a new era?
-
Ecker C, Spooren W, Murphy D (2013) Translational approaches to the biology of Autism: false dawn or a new era? Mol Psychiatry 18(4):435-42.
-
(2013)
Mol Psychiatry
, vol.18
, Issue.4
, pp. 435-442
-
-
Ecker, C.1
Spooren, W.2
Murphy, D.3
-
41
-
-
84856092811
-
Networking in Autism: Leveraging genetic, biomarker and model system findings in the search for new treatments
-
Veenstra-VanderWeele J, Blakely RD (2012) Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New Treatments Neuropsychopharmacology. 37(1):196-212.
-
(2012)
Neuropsychopharmacology
, vol.37
, Issue.1
, pp. 196-212
-
-
Veenstra-VanderWeele, J.1
Blakely, R.D.2
-
42
-
-
84868338744
-
EU-AIMS: A boost to autism research
-
Murphy D, Spooren W, (2012) EU-AIMS: a boost to autism research. Nat. Rev Drug Discov. 11:815-816
-
(2012)
Nat. Rev Drug Discov
, vol.11
, pp. 815-816
-
-
Murphy, D.1
Spooren, W.2
-
43
-
-
67650750977
-
A synaptic trek to autism
-
Bourgeron T (2009) A synaptic trek to autism. Curr Opin Neurobiol. 19(2):231-4.
-
(2009)
Curr Opin Neurobiol
, vol.19
, Issue.2
, pp. 231-234
-
-
Bourgeron, T.1
-
44
-
-
77957912870
-
The genetics of child psychiatric disorders: Focus on autism and Tourette syndrome
-
State MW (2010) The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron 68(2):254-69
-
(2010)
Neuron
, vol.68
, Issue.2
, pp. 254-269
-
-
State, M.W.1
-
45
-
-
84865208871
-
Rate of de novo mutations and the importance of father's age to disease risk
-
Kong A, Frig ML, Masson G, Besenbacher S, Sulem P, et al (2012) Rate of de novo mutations and the importance of father's age to disease risk Nature 4(8):471-475
-
(2012)
Nature
, vol.4
, Issue.8
, pp. 471-475
-
-
Kong, A.1
Frig, M.L.2
Masson, G.3
Besenbacher, S.4
Sulem, P.5
-
46
-
-
79952313620
-
Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting
-
Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting Brain Res 1380:42-77
-
(2011)
Brain Res
, vol.1380
, pp. 42-77
-
-
Betancur, C.1
-
47
-
-
84862659562
-
Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities
-
doi:pii: a009886
-
Zoghbi HY, Bear MF (2012) Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol. 4(3): doi:pii: a009886
-
(2012)
Cold Spring Harb. Perspect. Biol.
, vol.4
, Issue.3
-
-
Zoghbi, H.Y.1
Bear, M.F.2
-
48
-
-
84867229875
-
Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism
-
Baudoin SJ, Gaudias J, Gerharz S, Jatstatt L, Zhou K, et al (2012) Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism. Science 338 (6103) :128-132
-
(2012)
Science
, vol.338
, Issue.6103
, pp. 128-132
-
-
Baudoin, S.J.1
Gaudias, J.2
Gerharz, S.3
Jatstatt, L.4
Zhou, K.5
-
49
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
DOI 10.1093/annonc/mdl498
-
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol. 18(3):581-592. (Pubitemid 46359643)
-
(2007)
Annals of Oncology
, vol.18
, Issue.3
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
Heanue, M.4
Colombet, M.5
Boyle, P.6
-
50
-
-
84902184789
-
Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery
-
in press
-
Ruggeri BA, Camp F. (2013) Animal Models of Disease: Pre-clinical Animal Models of Cancer and Their Applications and Utility in Drug Discovery. Biochem Pharmacol, in press.
-
(2013)
Biochem Pharmacol
-
-
Ruggeri, B.A.1
Camp, F.2
-
51
-
-
78149284767
-
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
-
Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, et al (2010) RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468:103-107
-
(2010)
Nature
, vol.468
, pp. 103-107
-
-
Gonzalez-Suarez, E.1
Jacob, A.P.2
Jones, J.3
Miller, R.4
Roudier-Meyer, M.P.5
-
52
-
-
78649821635
-
Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression
-
Mukherjee A, Soyal SM, Li J, Ying Y, He B, et al (2010) Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 24:4408-4419
-
(2010)
FASEB J
, vol.24
, pp. 4408-4419
-
-
Mukherjee, A.1
Soyal, S.M.2
Li, J.3
Ying, Y.4
He, B.5
-
53
-
-
84864742990
-
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis
-
Sutton EE, Riche DM (2012) Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. Ann Pharmacother 46(7-8):1000-1009
-
(2012)
Ann Pharmacother
, vol.46
, Issue.7-8
, pp. 1000-1009
-
-
Sutton, E.E.1
Riche, D.M.2
-
54
-
-
84877748040
-
Progesterone/RANKL is a major regulatory axis in the human breast
-
Tanos T, Sflomos G, Echeverria PC, Ayyanan A, Gutierrez M, et al (2013) Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast. Sci. Transl. Med 5(182):182ra55
-
(2013)
Sci. Transl. Med
, vol.5
, Issue.182
-
-
Tanos, T.1
Sflomos, G.2
Echeverria, P.C.3
Ayyanan, A.4
Gutierrez, M.5
-
55
-
-
84881360676
-
In silico ADMET prediction: Recent advances, current challenges and future trends
-
Cheng F, Li W, Liu G, Tang Y (2013) In Silico ADMET Prediction: Recent Advances, Current Challenges and Future Trends. Curr Top Med Chem 13(11):1273-1289.
-
(2013)
Curr Top Med Chem
, vol.13
, Issue.11
, pp. 1273-1289
-
-
Cheng, F.1
Li, W.2
Liu, G.3
Tang, Y.4
-
56
-
-
84883451066
-
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
-
In press
-
Sutter A, Amberg A, Boyer S, Brigo A, Contrera JF, et al (2013) Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regul Toxicol Pharmacol. In press.
-
(2013)
Regul Toxicol Pharmacol
-
-
Sutter, A.1
Amberg, A.2
Boyer, S.3
Brigo, A.4
Contrera, J.F.5
-
57
-
-
84873048924
-
The eTOX library of public resources for in silico toxicity prediction
-
Cases M, Pastor M, Sanz F. (2013), The eTOX Library of Public Resources for in Silico Toxicity Prediction. Mol. Inf., 32:24-35
-
(2013)
Mol. Inf.
, vol.32
, pp. 24-35
-
-
Cases, M.1
Pastor, M.2
Sanz, F.3
-
58
-
-
79952159586
-
A multiscale simulation system for the prediction of drug-induced cardiotoxicity
-
Obiol-Pardo C, Gomis-Tena J, Sanz F, Saiz J, Pastor M (2011) A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model. 51(2):483-92
-
(2011)
J Chem Inf Model
, vol.51
, Issue.2
, pp. 483-492
-
-
Obiol-Pardo, C.1
Gomis-Tena, J.2
Sanz, F.3
Saiz, J.4
Pastor, M.5
-
59
-
-
84857979437
-
Application of data mining and visualization techniques for the prediction of drug-induced nausea in man
-
Parkinson J, Muthas D, Clark M, Boyer S, Valentin JP, et al (2012) Application of data mining and visualization techniques for the prediction of drug-induced nausea in man. Toxicol Sci. 126(1):275-84
-
(2012)
Toxicol Sci
, vol.126
, Issue.1
, pp. 275-284
-
-
Parkinson, J.1
Muthas, D.2
Clark, M.3
Boyer, S.4
Valentin, J.P.5
-
60
-
-
84883246246
-
Scientific competency questions as the basis for semantically enriched open pharmacological space development
-
in Press
-
Azzaoui K, Jacoby E, Senger S, Rodriguez EC, Loza M, et al (2013) Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today. In Press
-
(2013)
Drug Discov Today
-
-
Azzaoui, K.1
Jacoby, E.2
Senger, S.3
Rodriguez, E.C.4
Loza, M.5
-
61
-
-
84875166951
-
European lead factory opens for business
-
Mullard A (2013) European lead factory opens for business. Nat Rev Drug Discov. 12(3):173-5.
-
(2013)
Nat Rev Drug Discov
, vol.12
, Issue.3
, pp. 173-175
-
-
Mullard, A.1
-
62
-
-
67650506936
-
Open access chemical and clinical probes to support drug discovery
-
Edwards AM, Bountra C, Kerr DJ, Willson TM (2009) Open access chemical and clinical probes to support drug discovery. Nat Chem Biol. 5(7):436-40
-
(2009)
Nat Chem Biol
, vol.5
, Issue.7
, pp. 436-440
-
-
Edwards, A.M.1
Bountra, C.2
Kerr, D.J.3
Willson, T.M.4
-
63
-
-
84860371953
-
Epigenetic protein families: A new frontier for drug discovery
-
Arrowsmith CH, Bountra C, Fish PV, Lee K, Shapira M (2012) Epigenetic protein families: a new frontier for drug discovery Nat. Rev. Drug Discov. 11:384-400
-
(2012)
Nat. Rev. Drug Discov
, vol.11
, pp. 384-400
-
-
Arrowsmith, C.H.1
Bountra, C.2
Fish, P.V.3
Lee, K.4
Shapira, M.5
-
64
-
-
33748325882
-
Drug-target residence time and its implications for lead optimization
-
DOI 10.1038/nrd2082, PII NRD2082
-
Copeland, RA, Pompliano DL, Meek TD (2006) Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 5:730-739. (Pubitemid 44323700)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.9
, pp. 730-739
-
-
Copeland, R.A.1
Pompliano, D.L.2
Meek, T.D.3
-
65
-
-
58449131873
-
The role of binding kinetics in therapeutically useful drug action
-
Swinney DC (2009) The role of binding kinetics in therapeutically useful drug action. Curr Opin Drug Discov Devel 12:31-39
-
(2009)
Curr Opin Drug Discov Devel
, vol.12
, pp. 31-39
-
-
Swinney, D.C.1
-
66
-
-
67649973722
-
The importance of drug-target residence time
-
Zhang R, Monsma F (2009) The importance of drug-target residence time. Curr Opin Drug Discov Devel 12:488-96.
-
(2009)
Curr Opin Drug Discov Devel
, vol.12
, pp. 488-496
-
-
Zhang, R.1
Monsma, F.2
-
67
-
-
33646122469
-
Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety
-
Swinney DC (2006) Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001-2004: mechanisms leading to optimal efficacy and safety. Curr Top Med Chem 6:461-478.
-
(2006)
Curr Top Med Chem
, vol.6
, pp. 461-478
-
-
Swinney, D.C.1
|